IFNG and B-cell acute lymphoblastic leukemia: Diorio et al. performed comprehensive serum proteome profiling in patients with B-cell acute lymphoblastic leukemia (B-ALL) receiving CART19 therapy and identified significant elevations in cytokines such as IFNγ, which plays a fundamental role in CRS [6].